Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia (Q33518973)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia
scientific article

    Statements

    Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia (English)
    Seval Türkmen
    Michaela Schwarz
    Gökben Koca
    Hendrik Nogai
    Christiane Bommer
    Bernd Dörken
    Peter Daniel
    Philipp le Coutre
    16 December 2009

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit